These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1579084)

  • 21. Capsular Polysaccharide (CPS) Release by Serotype 3 Pneumococcal Strains Reduces the Protective Effect of Anti-Type 3 CPS Antibodies.
    Choi EH; Zhang F; Lu YJ; Malley R
    Clin Vaccine Immunol; 2016 Feb; 23(2):162-7. PubMed ID: 26677201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proportion of protein A bindable molecules in human IgM and IgA antibodies to seven antigens.
    Ibrahim S; Seppälä IJ; Sarvas H; Mäkelä O
    Microb Pathog; 1993 Sep; 15(3):159-68. PubMed ID: 8271916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
    Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
    J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies elicited by pneumococcal antigens bear an anti-DNA--associated idiotype.
    Grayzel A; Solomon A; Aranow C; Diamond B
    J Clin Invest; 1991 Mar; 87(3):842-6. PubMed ID: 1999497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults.
    Schauer U; Stemberg F; Rieger CH; Büttner W; Borte M; Schubert S; Möllers H; Riedel F; Herz U; Renz H; Herzog W
    Clin Diagn Lab Immunol; 2003 Mar; 10(2):202-7. PubMed ID: 12626443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children.
    Claesson BA; Trollfors B; Lagergard T; Taranger J; Bryla D; Otterman G; Cramton T; Yang Y; Reimer CB; Robbins JB
    J Pediatr; 1988 May; 112(5):695-702. PubMed ID: 3361379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3.
    Snippe H; van Houte AJ; van Dam JE; De Reuver MJ; Jansze M; Willers JM
    Infect Immun; 1983 Jun; 40(3):856-61. PubMed ID: 6852923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.
    Jennings HJ; Roy R; Gamian A
    J Immunol; 1986 Sep; 137(5):1708-13. PubMed ID: 3091688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-function studies of human monoclonal antibodies to pneumococcus type 3 polysaccharide.
    Shaw DR; Kirkham P; Schroeder HW; Roben P; Silverman GJ
    Ann N Y Acad Sci; 1995 Sep; 764():370-3. PubMed ID: 7486548
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary murine immunoglobulin M responses to certain pneumococcal capsular polysaccharides consist primarily of anti-pneumococcal cell wall carbohydrate antibodies.
    Fairchild RL; Sterner KE; Braley-Mullen H
    Infect Immun; 1986 Jun; 52(3):867-71. PubMed ID: 3710589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity.
    Laferrière CA; Sood RK; de Muys JM; Michon F; Jennings HJ
    Vaccine; 1997 Feb; 15(2):179-86. PubMed ID: 9066036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections.
    Sanders LA; Rijkers GT; Kuis W; Tenbergen-Meekes AJ; de Graeff-Meeder BR; Hiemstra I; Zegers BJ
    J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):110-9. PubMed ID: 8423268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.
    Jennings HJ; Lugowski C
    J Immunol; 1981 Sep; 127(3):1011-8. PubMed ID: 6790606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid.
    Lagergard T; Shiloach J; Robbins JB; Schneerson R
    Infect Immun; 1990 Mar; 58(3):687-94. PubMed ID: 2407652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzyme immunoassay for detection of immunoglobulin G (IgG), IgM, and IgA antibodies against type 6B pneumococcal capsular polysaccharide and cell wall C polysaccharide in chinchilla serum.
    Koskela M; Harris M; Giebink GS
    J Clin Microbiol; 1992 Jun; 30(6):1485-90. PubMed ID: 1624568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide.
    Alonso de Velasco E; Verheul AF; Veeneman GH; Gomes LJ; van Boom JH; Verhoef J; Snippe H
    Vaccine; 1993 Nov; 11(14):1429-36. PubMed ID: 8310762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The human in vitro anti-type 4 pneumococcal polysaccharide antibody response is regulated by suppressor T cells.
    Griffioen AW; Rijkers GT; Toebes EA; Zegers BJ
    Scand J Immunol; 1991 Aug; 34(2):229-36. PubMed ID: 1830972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates.
    Verheul AF; Versteeg AA; De Reuver MJ; Jansze M; Snippe H
    Infect Immun; 1989 Apr; 57(4):1078-83. PubMed ID: 2925240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Models for assessing the effect of toxicants on immunocompetence in mice. II. Effect of cyclophosphamide on the antibody responses to type III pneumococcal polysaccharide and tetanus toxoid in BALB/c female mice.
    Speirs RS; Benson RW; Knowles BJ; Roberts D
    J Environ Pathol Toxicol; 1978; 1(6):791-812. PubMed ID: 32218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of pneumococcal capsular polysaccharide-protein conjugate vaccines utilizing new fragmentation and conjugation technologies.
    Pawlowski A; Källenius G; Svenson SB
    Vaccine; 2000 Mar; 18(18):1873-85. PubMed ID: 10699336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.